{"Benefit_Risk":"Benefit","Category":"Grp1","Subcategory":"PFS","Type":"Hazard Ratio","Type_short":"HR","Treatment":"150/2 vs. Mono","Big_N1":16,"Small_N1":10,"Big_N2":18,"Small_N2":"","Point_Est":0.39,"LCI":0.25,"UCI":0.62,"Scale":"log","Reverse":"","Anno1":"","Anno2":""}
{"Benefit_Risk":"Benefit","Category":"Grp1","Subcategory":"PFS","Type":"Hazard Ratio","Type_short":"HR","Treatment":"150/1 vs. Mono","Big_N1":16,"Small_N1":14,"Big_N2":23,"Small_N2":"","Point_Est":0.56,"LCI":0.37,"UCI":0.87,"Scale":"log","Reverse":"","Anno1":"","Anno2":""}
{"Benefit_Risk":"Benefit","Category":"Grp2","Subcategory":"Response Rate","Type":"Difference in RR","Type_short":"RR Diff","Treatment":"150/2 vs. Mono","Big_N1":20,"Small_N1":18,"Small_N2":"20","Point_Est":22,"LCI":2.5,"UCI":40.7,"Scale":"linear","Reverse":"Y","Anno1":"","Anno2":""}
{"Benefit_Risk":"Benefit","Category":"Grp2","Subcategory":"Response Rate","Type":"Difference in RR","Type_short":"RR Diff","Treatment":"150/1 vs. Mono","Big_N1":31,"Small_N1":17,"Small_N2":"16","Point_Est":-4,"LCI":-23.1,"UCI":15.9,"Scale":"linear","Reverse":"Y","Anno1":"","Anno2":""}
{"Benefit_Risk":"Benefit","Category":"Grp3","Subcategory":"Cutaneuous SCC (Including Keratoacanthoma)","Type":"Risk Difference","Type_short":"RiskDiff","Treatment":"150/1 vs. Mono","Big_N1":22,"Small_N1":14,"Big_N2":24,"Small_N2":"21","Point_Est":-17,"LCI":-28.1,"UCI":-5.9,"Scale":"linear","Reverse":"","Anno1":"","Anno2":""}
{"Benefit_Risk":"Benefit","Category":"Grp3","Subcategory":"Cutaneuous SCC (Including Keratoacanthoma)","Type":"Risk Difference","Type_short":"RiskDiff","Treatment":"150/2 vs. Mono","Big_N1":11,"Small_N1":9,"Big_N2":13,"Small_N2":"11","Point_Est":-11.6,"LCI":-24.2,"UCI":1,"Scale":"linear","Reverse":"","Anno1":"","Anno2":""}
{"Benefit_Risk":"Risk","Category":"Grp4","Subcategory":"Chorioretinopathy","Type":"Risk Difference","Type_short":"RiskDiff","Treatment":"150/1 vs. Mono","Small_N2":"                           xcv","Scale":"linear","Reverse":"","Anno1":"Test Annotation 1","Anno1pos":-20,"Anno2":"Test Annotation 2","Anno2pos":10}
{"Benefit_Risk":"Risk","Category":"Grp4","Subcategory":"Chorioretinopathy","Type":"Risk Difference","Type_short":"RiskDiff","Treatment":"150/2 vs. Mono","Big_N1":7,"Small_N1":6,"Big_N2":9,"Small_N2":"5","Point_Est":1.8,"LCI":-1.7,"UCI":5.3,"Scale":"linear","Reverse":"","Anno1":"","Anno2":""}
{"Benefit_Risk":"Risk","Category":"Grp4","Subcategory":"Hypertension","Type":"Risk Difference","Type_short":"RiskDiff","Treatment":"150/1 vs. Mono","Big_N1":11,"Small_N1":10,"Big_N2":16,"Small_N2":"11","Point_Est":-0.1,"LCI":-7.3,"UCI":7.1,"Scale":"linear","Reverse":"","Anno1":"","Anno2":""}
{"Benefit_Risk":"Risk","Category":"Grp4","Subcategory":"Hypertension","Type":"Risk Difference","Type_short":"RiskDiff","Treatment":"150/2 vs. Mono","Big_N1":19,"Small_N1":12,"Big_N2":20,"Small_N2":"7","Point_Est":5.3,"LCI":-3.9,"UCI":14.5,"Scale":"linear","Reverse":"","Anno1":"","Anno2":""}
{"Benefit_Risk":"Risk","Category":"Grp4","Subcategory":"Alanine aminotransferase increased","Type":"Risk Difference","Type_short":"RiskDiff","Treatment":"150/1 vs. Mono","Big_N1":12,"Small_N1":9,"Big_N2":9,"Small_N2":"5","Point_Est":18.5,"LCI":7.1,"UCI":29.8,"Scale":"linear","Reverse":"","Anno1":"","Anno2":""}
{"Benefit_Risk":"Risk","Category":"Grp4","Subcategory":"Alanine aminotransferase increased","Type":"Risk Difference","Type_short":"RiskDiff","Treatment":"150/2 vs. Mono","Big_N1":25,"Small_N1":19,"Big_N2":32,"Small_N2":"16","Point_Est":7.2,"LCI":-1.2,"UCI":15.6,"Scale":"linear","Reverse":"","Anno1":"","Anno2":""}
{"Benefit_Risk":"Risk","Category":"Grp4","Subcategory":"Aspartate aminotransferase increased","Type":"Risk Difference","Type_short":"RiskDiff","Treatment":"150/1 vs. Mono","Big_N1":21,"Small_N1":16,"Big_N2":26,"Small_N2":"13","Point_Est":16.6,"LCI":5.6,"UCI":27.6,"Scale":"linear","Reverse":"","Anno1":"","Anno2":""}
{"Benefit_Risk":"Risk","Category":"Grp4","Subcategory":"Aspartate aminotransferase increased","Type":"Risk Difference","Type_short":"RiskDiff","Treatment":"150/2 vs. Mono","Big_N1":14,"Small_N1":8,"Big_N2":11,"Small_N2":"11","Point_Est":7.2,"LCI":-1.2,"UCI":15.6,"Scale":"linear","Reverse":"","Anno1":"","Anno2":""}
{"Benefit_Risk":"Risk","Category":"Grp4","Subcategory":"Ejection fraction decreased","Type":"Risk Difference","Type_short":"RiskDiff","Treatment":"150/1 vs. Mono","Big_N1":18,"Small_N1":14,"Big_N2":14,"Small_N2":"16","Point_Est":3.7,"LCI":-1.3,"UCI":8.7,"Scale":"linear","Reverse":"","Anno1":"","Anno2":""}
{"Benefit_Risk":"Risk","Category":"Grp4","Subcategory":"Ejection fraction decreased","Type":"Risk Difference","Type_short":"RiskDiff","Treatment":"150/2 vs. Mono","Big_N1":5,"Small_N1":5,"Big_N2":5,"Small_N2":"5","Point_Est":9.1,"LCI":1.5,"UCI":16.7,"Scale":"linear","Reverse":"","Anno1":"","Anno2":""}
{"Benefit_Risk":"Risk","Category":"Grp4","Subcategory":"Dermatitis acneiform","Type":"Risk Difference","Type_short":"RiskDiff","Treatment":"150/1 vs. Mono","Big_N1":20,"Small_N1":15,"Big_N2":14,"Small_N2":"11","Point_Est":7.3,"LCI":-2.5,"UCI":17.2,"Scale":"linear","Reverse":"","Anno1":"","Anno2":""}
{"Benefit_Risk":"Risk","Category":"Grp4","Subcategory":"Dermatitis acneiform","Type":"Risk Difference","Type_short":"RiskDiff","Treatment":"150/2 vs. Mono","Big_N1":23,"Small_N1":16,"Big_N2":26,"Small_N2":"12","Point_Est":12.6,"LCI":1.5,"UCI":23.6,"Scale":"linear","Reverse":"","Anno1":"","Anno2":""}